Circle Health Group
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Circle Health Group - overview
Established
2004
Location
London, England, UK
Primary Industry
Healthcare
About
Based in the UK, Circle Health Group provides a wide range of private healthcare services, focusing on surgical and medical treatments while prioritizing patient care and accessibility. Circle Health Group, founded in 2004 and headquartered in London, UK, is a provider of private healthcare services. The company underwent a significant transformation when Centene Corp acquired a 60% majority stake in July 2021 for USD 705 mn, enabling the expansion of their services. Timothy P, the founder, has been instrumental in the company's development and growth, establishing a network of healthcare facilities across England, Scotland, and Wales.
Circle Health Group specializes in a comprehensive array of private healthcare services, including orthopaedic surgery, cardiology, gynaecology, urology, dermatology, ophthalmology, and general surgery. These services cater to diverse healthcare needs, emphasizing personalized care and a superior patient experience. The company serves a broad clientele, including self-paying patients and those with private health insurance, with locations across the UK to ensure timely access to healthcare solutions. In the most recent fiscal year of 2023, Circle Health Group reported revenue of USD 0 and an EBITDA of USD -9,217,559.
30, reflecting the company's current financial position amid its ongoing expansions and strategic changes. Following the acquisition by Centene Corp, Circle Health Group plans to enhance its healthcare treatment services to better meet patient demands. There are specific strategies in place to expand into new geographic regions, further enhancing access to their offerings. The recent funding of USD 705 mn will support these initiatives, allowing the company to strengthen its infrastructure and service capabilities.
Current Investors
Maven Capital Partners, Penta Capital, Toscafund Asset Management
Primary Industry
Healthcare
Sub Industries
Molecular Science, Genetics & Gene Therapy, Aesthetic Medicine, Hospitals, Cardiology
Website
www.circlehealthgroup.co.uk/
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Circle Health Group - timeline of key events
Circle Health Group - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 76,164,000 | 74,319,000 | 72,949,000 | 84,109,000 | 1,196,000 | 1,773,000 | 3,967,000 | 5,395,000 | 6,064,000 | 5,327,000 | 4,423,000 | 4,545,000 | - | - | - |
| % Revenue Growth (YoY) | - | (2.4%) | (1.8%) | 15.3% | (98.6%) | 48.2% | 123.7% | 36.0% | 12.4% | (12.2%) | (17.0%) | 2.8% | - | - | - |
| EBITDA (USD) | (13,068,000) | (11,936,000) | (12,949,000) | (12,485,000) | (37,711,000) | 141,872,000 | (7,641,000) | (56,069,000) | (13,775,000) | (4,781,000) | 51,377,000 | (56,047,000) | - | - | - |
| Operating Income (USD) | (31,092,000) | (19,633,000) | (25,659,000) | (17,071,000) | (38,103,000) | 141,654,000 | (7,855,000) | (56,415,000) | (14,111,000) | (5,384,000) | 50,663,000 | (56,988,000) | - | - | - |
| Operating Margin | (40.8%) | (26.4%) | (35.2%) | (20.3%) | (3185.9%) | 7989.5% | (198.0%) | (1045.7%) | (232.7%) | (101.1%) | 1145.4% | (1253.9%) | - | - | - |
| % EBITDA Margin | (17.2%) | (16.1%) | (17.8%) | (14.8%) | (3153.1%) | 8001.8% | (192.6%) | (1039.3%) | (227.2%) | (89.8%) | 1161.6% | (1233.2%) | - | - | - |
| NET Income (USD) | (44,114,000) | (28,538,000) | (38,041,000) | (45,690,000) | (51,152,000) | 136,828,000 | (7,675,000) | (56,208,000) | (13,413,000) | (4,591,000) | 52,138,000 | (56,658,000) | - | - | - |
| % Net Margin | (57.9%) | (38.4%) | (52.1%) | (54.3%) | (4276.9%) | 7717.3% | (193.5%) | (1041.9%) | (221.2%) | (86.2%) | 1178.8% | (1246.6%) | - | - | - |
Circle Health Group - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Circle Health Group | - | ||||||||
| Buyout | Completed | Circle Health Group | - | ||||||||
| Add-on | Completed | BMI Healthcare (Circle Health Group) | - | ||||||||
| Public to Private | Completed | Circle Health Group | - |
Displaying 1 - 4 of 4
Circle Health Group - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.